New System Reduces Pain in Bone Marrow Biopsies

The OnControl bone marrow biopsy system enables the clinician performing the procedure to quickly and precisely enter the intraosseous space and successfully capture a core with minimal patient discomfort or pain. The system utilizes advanced technology to improve the speed, control, and patient comfort of the procedure. The system also decreases insertion time, lowers patient pain scores, and has been shown to be particularly helpful in aspirations of the fragile bones of elderly patients as well as harder bones of athletes.

The system uses a lithium-powered driver connected to a patented 11 gauge, 102 mm or 152 mm needles with specialized bi-beveled cutting tips. The cannula features a standard luer-lock connector. The system includes a biopsy tray designed to simplify needle set access and usage while maintaining a sterile environment. A training package designed to provide a realistic sensation of needle placement is available. The OnControl Biopsy System is a product of Vidacare (San Antonio, TX, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"Bone marrow biopsies are the most frequently performed intraosseous diagnostic procedure in the U.S. and around the world,” said Philip Faris Jr., CEO and president of Vidacare. "Virtually unchanged for decades, the manual procedure causes pain rated as severe to worst possible pain by nearly 20% of patients participating in a recent study.”

Bone marrow biopsy (trephine) procedures are necessary for the diagnosis and management of lymphoma, leukemia, myeloma, and other hematological disorders, and have historically been very painful for patients.


Related Links:
Vidacare